Updates on New Therapies for Patients with CKD

An algorithm when ARNI, SGLT2i, and finerenone can be used

Choosing the right candidates for newer therapies is crucial due to their cost, potential side effects, and the need to follow selection criteria from key clinical trials.

Abbreviations ▼

ACEi: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin II receptor blocker; ARNI: Angiotensin receptor/neprilysin inhibitor; CKD: Chronic kidney disease; eGFR: Estimated glomerular filtration rate; GLP-1: Glucagon-like peptide-1; HF: Heart failure; SGLT2i: Sodium glucose transporter 2 inhibitor; UACR: Urine albumin-to-creatinine ratio.

References ▼

Tian R, Li R, Zhou X. Recent progresses in non-dialysis chronic kidney disease patients with hyperkalemia: Outcomes and therapeutic strategies. Medicina (Kaunas). 2023;59(2):353.

LMRC Code: GGI-CO-A1-AQS-300030873-BANNERS-I24-1528

Disclaimer: For the use of a Registered Medical Practitioner, Hospital or Laboratory only.

The images are for illustrative representation only and do not depict actual medical products, procedures, or outcomes. Refer to official medical guidance and product information for accurate details.

All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.

Updates on New Therapies for Patients with CKD

Related Articles

Login to continue